<?xml version="1.0" encoding="UTF-8"?>
<ref id="B195">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wilder-Smith</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vannice</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Durbin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hombach</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>S. J.</given-names>
   </name>
   <name>
    <surname>Thevarjan</surname>
    <given-names>I.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Zika vaccines and therapeutics: landscape analysis and challenges ahead.</article-title>
  <source>
   <italic>BMC Med.</italic>
  </source>
  <volume>16</volume>:
  <issue>84</issue>. 
  <pub-id pub-id-type="doi">10.1186/s12916-018-1067-x</pub-id>
  <?supplied-pmid 29871628?>
  <pub-id pub-id-type="pmid">29871628</pub-id>
 </mixed-citation>
</ref>
